Apply This IPO

Best Margin

Zero Brokerage

24*7 Customer Support.

Fastest mobile support

---

Apply with Angel One

Apply with Zerodha

Pre-Apply with Upstox

Quest Laboratories Limited IPO Review

Quest Laboratories Limited engaged in manufactures a wide range of pharmaceutical products, including treatments for infections, malaria, spasms, inflammation, nausea, respiratory issues, diabetes, depression, and more. Their products include branded drugs, generics, and over-the-counter medications. Over the past few years, their product range has grown as they've added new categories. They continually expand their offerings through research and development of new pharmaceuticals. They have an in-house Department of Formulation Development, Quality Control, and Product Stability Studies that works on creating and testing different versions of their existing products. They conduct process validations, analytical method validations, and cleaning validations following standard procedures.

Their company regularly receives sales orders from both private businesses and government agencies. This collaboration benefits buyers by offering cost savings through bulk production, the ability to scale up, regulatory compliance, shorter lead times, risk reduction, access to specialized technology, geographical expansion, affordable compliance, and efficient use of resources.

Quest Laboratories Limited Products and Services

Quest Laboratories Limited makes a variety of medicines, including branded drugs, generics, and over the counter (OTC) products. These medicines come in different forms like tablets, liquid syrups, dry powders, ORS powders, ointments, and external liquids. This variety helps the company meet the diverse medical needs and preferences of patients.

Their skilled staff ensures lab results and services are trustworthy. Their expertise helps them maintain accuracy, follow protocols, and provide timely results, which are crucial in the pharmaceutical industry. Having these capabilities in-house allows them to support product development, quality control, and regulatory compliance. This has earned them a reputation as a reliable and efficient lab service provider. Their Strengths are multi-product capability, Revenue from Government institutions, Product Portfolio, Research and Development, Quality assurance.

Financial Overview  

The company operates in a very competitive and fragmented market. It has seen huge profits since FY22, which has raised questions about whether this success can continue. Given the high earnings in FY24, the stock seems to be fully valued. Investors who are well-informed or have extra cash might consider investing a moderate amount for the medium term.